350 related articles for article (PubMed ID: 19843266)
41. Doping and supplementation: the attitudes of talented young athletes.
Bloodworth AJ; Petróczi A; Bailey R; Pearce G; McNamee MJ
Scand J Med Sci Sports; 2012 Apr; 22(2):293-301. PubMed ID: 20973831
[TBL] [Abstract][Full Text] [Related]
42. [Doping--a medical problem in Denmark?].
Keld DB; Bendsen AK
Ugeskr Laeger; 1998 Aug; 160(33):4749-53. PubMed ID: 9715655
[TBL] [Abstract][Full Text] [Related]
43. [Estimated consumption of anabolic steroids among athletes in Denmark].
Fauner M; Kisling A; Nielsen SL
Nord Med; 1995; 110(1):23-5. PubMed ID: 7831105
[TBL] [Abstract][Full Text] [Related]
44. Popular ergogenic drugs and supplements in young athletes.
Calfee R; Fadale P
Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
[TBL] [Abstract][Full Text] [Related]
45. Substance use in athletics: a sports psychiatry perspective.
McDuff DR; Baron D
Clin Sports Med; 2005 Oct; 24(4):885-97, ix-x. PubMed ID: 16169452
[TBL] [Abstract][Full Text] [Related]
46. [Banned performance enhancing ergogenic aids in children and adolescent athletes].
Nemet D; Eliakim A
Harefuah; 2007 Oct; 146(10):794-9, 812. PubMed ID: 17990397
[TBL] [Abstract][Full Text] [Related]
47. Anabolic-Androgenic Steroid Use in Sports, Health, and Society.
Bhasin S; Hatfield DL; Hoffman JR; Kraemer WJ; Labotz M; Phillips SM; Ratamess NA
Med Sci Sports Exerc; 2021 Aug; 53(8):1778-1794. PubMed ID: 34261998
[TBL] [Abstract][Full Text] [Related]
48. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
Chester N; Wojek N
Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
[TBL] [Abstract][Full Text] [Related]
49. Use of doping agents, particularly anabolic steroids, in sports and society.
Sjöqvist F; Garle M; Rane A
Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
[TBL] [Abstract][Full Text] [Related]
50. Problems of the use of pseudoephedrine by athletes.
Pokrywka A; Tszyrsznic W; Kwiatkowska DJ
Int J Sports Med; 2009 Aug; 30(8):569-72. PubMed ID: 19382058
[TBL] [Abstract][Full Text] [Related]
51. Late specialization: the key to success in centimeters, grams, or seconds (cgs) sports.
Moesch K; Elbe AM; Hauge ML; Wikman JM
Scand J Med Sci Sports; 2011 Dec; 21(6):e282-90. PubMed ID: 21401722
[TBL] [Abstract][Full Text] [Related]
52. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
Anawalt BD
Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
[TBL] [Abstract][Full Text] [Related]
53. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
Bahrke MS; Yesalis CE
Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
[TBL] [Abstract][Full Text] [Related]
54. Aortic elastic properties in athletes using anabolic-androgenic steroids.
Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
[TBL] [Abstract][Full Text] [Related]
55. [Anabolic steroids in athletes].
Yesalis CE; Wright JE; Lombardo JA
Wien Med Wochenschr; 1992; 142(14):298-308. PubMed ID: 1441566
[TBL] [Abstract][Full Text] [Related]
56. Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study.
Piacentino D; Kotzalidis GD; Longo L; Pavan A; Stivali L; Stivali G; Ferracuti S; Brugnoli R; Frati P; Fineschi V; Girardi P; Sani G
J Psychoactive Drugs; 2017; 49(5):373-384. PubMed ID: 28777732
[TBL] [Abstract][Full Text] [Related]
57. Sports medicine: performance-enhancing drugs.
Gregory AJ; Fitch RW
Pediatr Clin North Am; 2007 Aug; 54(4):797-806, xii. PubMed ID: 17723878
[TBL] [Abstract][Full Text] [Related]
58. Knowledge, attitudes and practices of anabolic steroid usage among gym users in Trinidad.
Maharaj VR; Dookie T; Mohammed S; Ince S; Marsang BL; Rambocas N; Chin M; McDougall L; Teelucksingh S
West Indian Med J; 2000 Mar; 49(1):55-8. PubMed ID: 10786454
[TBL] [Abstract][Full Text] [Related]
59. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
60. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
